Status:
COMPLETED
Detection of Chemotherapy Induced Cardiotoxicity
Lead Sponsor:
George Washington University
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
To identify patients that are at risk of heart damage after receiving chemotherapy (adriamycin).
Detailed Description
To identify patients at risk of development of heart damage after receiving chemotherapy by obtaining the genetic profile of those who show: elevation of troponin, left ventricular systolic and diasto...
Eligibility Criteria
Inclusion
- undergoing anthracycline and/or trastuzumab therapy for the first time
Exclusion
- abnormal ventricular ejection fraction
- past history of, or active cardiac disease including: MI, CHF, angina, arrhythmia requiring medication, valvular disease, uncontrolled systemic hypertension
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00636844
Start Date
January 1 2008
End Date
June 1 2012
Last Update
March 13 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
George Washington University
Washington D.C., District of Columbia, United States, 20037